[Vascular risk in endocrine diseases other than diabetes].

Autor:	Antequera I; Servicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, Málaga, España. Electronic address: antequera.isabel@gmail.com., Cuende JI; Servicio de Medicina Interna, Complejo Asistencial Universitario de Palencia, Palencia, España., Nieto López-Guerrero J; Servicio de Medicina Interna, Hospital de Cantoblanco, Madrid, España., Valdivielso P; Servicio de Medicina Interna, Hospital Universitario Virgen de la Victoria, Málaga, España.
Jazyk:	Spanish; Castilian
Zdroj:	Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis [Clin Investig Arterioscler] 2016 Jul-Aug; Vol. 28 (4), pp. 197-201. Date of Electronic Publication: 2015 Jul 04.
DOI:	10.1016/j.arteri.2015.05.001
Abstrakt:	Endocrinological diseases directly affect the cardiovascular system. The deleterious effects on cardiovascular function can be direct, and linked to the increase or reduction of circulating hormones. Equally, the adverse effects may be indirect; for example following the rise in blood pressure, increase or redistribution of lean mass, or increased plasma lipoproteins. The best health care and the increasing availability of biochemical tests lead to the diagnosis of many endocrine diseases before the onset of clinical signs. This review will focus on presenting evidence of cardiovascular functional or structural impairment in cases of primary hyperparathyroidism, Cushing's syndrome, and hypothyroidism in their sub-clinical forms, as well as the reversibility of complications after appropriate treatment. (Copyright © 2015 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu